Community Hospital of Los Gatos
Los Gatos, California 95032
0 studies enrolling now · 24 studies all time
What they study most
Adult Type Ovarian Granulosa Cell Tumor, Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Gestational Trophoblastic Tumor, Ovarian Cancer, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor, Ovarian Sex Cord Tumor With Annular Tubules, Ovarian Steroid Cell Tumor, Primary Peritoneal Cavity Cancer, Recurrent Uterine Corpus Carcinoma
Studies at this site
- Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer — Completed
- Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer — Completed
- Paclitaxel in Treating Patients With Ovarian Stromal Cancer — Completed
- Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer — Status unconfirmed
- Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer — Completed
- Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
- Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
- Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer — Stopped early
- Chemotherapy in Treating Patients With Sarcoma of the Uterus — Completed
- Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer — Stopped early
- Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva — Stopped early
- Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia — Completed
- Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer — Completed
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer — Completed
- Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy — Completed
- Quality of Life in Survivors of Gynecologic Cancer — Completed
- Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer — Stopped early
- Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix — Stopped early
- Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix — Stopped early
- Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer — Stopped early
- Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus — Stopped early
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer — Stopped early
- Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix — Stopped early
- Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer — Completed